164 related articles for article (PubMed ID: 16113329)
21. Redundancy of interleukin-6 in the differentiation of T cell and monocyte subsets during cutaneous leishmaniasis.
Kling J; Gollan R; Fromm P; Körner H
Exp Parasitol; 2011 Nov; 129(3):270-6. PubMed ID: 21819984
[TBL] [Abstract][Full Text] [Related]
22. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
[TBL] [Abstract][Full Text] [Related]
23. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages.
Corraliza IM; Soler G; Eichmann K; Modolell M
Biochem Biophys Res Commun; 1995 Jan; 206(2):667-73. PubMed ID: 7530004
[TBL] [Abstract][Full Text] [Related]
24. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
25. Some of the early events underlying Th2 cell maturation and susceptibility to Leishmania major infection in BALB/c mice.
Himmelrich H; Launois P; Tacchini-Cottier F; Louis JA
Biol Chem; 1999; 380(7-8):909-14. PubMed ID: 10494841
[TBL] [Abstract][Full Text] [Related]
26. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
27. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice.
Thüring H; Stenger S; Gmehling D; Röllinghoff M; Bogdan C
Eur J Immunol; 1995 Dec; 25(12):3229-34. PubMed ID: 8566005
[TBL] [Abstract][Full Text] [Related]
28. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.
Sacks D; Anderson C
Immunol Rev; 2004 Oct; 201():225-38. PubMed ID: 15361244
[TBL] [Abstract][Full Text] [Related]
29. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.
Sunderkötter C; Kunz M; Steinbrink K; Meinardus-Hager G; Goebeler M; Bildau H; Sorg C
J Immunol; 1993 Nov; 151(9):4891-901. PubMed ID: 8409447
[TBL] [Abstract][Full Text] [Related]
30. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
31. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
[TBL] [Abstract][Full Text] [Related]
33. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages.
Cuervo H; Pineda MA; Aoki MP; Gea S; Fresno M; Gironès N
J Infect Dis; 2008 Jun; 197(12):1772-82. PubMed ID: 18473687
[TBL] [Abstract][Full Text] [Related]
35. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
[TBL] [Abstract][Full Text] [Related]
36. STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With
Kauffmann F; Meert E; de Jonge K; Elkrim Y; Hanot Mambres D; Denis O; Muraille E; Magez S; De Trez C
Front Immunol; 2018; 9():503. PubMed ID: 29593739
[No Abstract] [Full Text] [Related]
37. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
38. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P
J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209
[TBL] [Abstract][Full Text] [Related]
39. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
40. Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect.
Duleu S; Vincendeau P; Courtois P; Semballa S; Lagroye I; Daulouède S; Boucher JL; Wilson KT; Veyret B; Gobert AP
J Immunol; 2004 May; 172(10):6298-303. PubMed ID: 15128819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
